These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 1299810)

  • 21. Antiendotoxin antibodies: a dead end?
    Cross AS
    Ann Intern Med; 1994 Jul; 121(1):58-60. PubMed ID: 8198349
    [No Abstract]   [Full Text] [Related]  

  • 22. The French National Registry of HA-1A (Centoxin) in septic shock. A cohort study of 600 patients. The National Committee for the Evaluation of Centoxin.
    Arch Intern Med; 1994 Nov; 154(21):2484-91. PubMed ID: 7979845
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lessons learned from clinical trials on monoclonal anti-endotoxin antibody.
    Weil MH
    Arch Intern Med; 1994 Jun; 154(11):1183. PubMed ID: 8203986
    [No Abstract]   [Full Text] [Related]  

  • 24. Novel approaches to the treatment of sepsis: lessons learned and future directions.
    Cross A
    Shock; 1996; 6 Suppl 1():S71-4. PubMed ID: 8828101
    [No Abstract]   [Full Text] [Related]  

  • 25. Immunotherapy with antibodies to core lipopolysaccharide: a critical appraisal.
    Baumgartner JD
    Infect Dis Clin North Am; 1991 Dec; 5(4):915-27. PubMed ID: 1723740
    [TBL] [Abstract][Full Text] [Related]  

  • 26. New immunotherapies for sepsis.
    Young LS; Wenzel RP
    Proc Assoc Am Physicians; 1995 Oct; 107(3):361-4. PubMed ID: 8608423
    [No Abstract]   [Full Text] [Related]  

  • 27. [Monoclonal antibodies in the treatment of septic shock].
    Trilla A; Alonso P
    Med Clin (Barc); 1992 Dec; 99(20):778-80. PubMed ID: 1460950
    [No Abstract]   [Full Text] [Related]  

  • 28. Monoclonal antibodies to endotoxin in the management of sepsis.
    Fang KC
    West J Med; 1993 Apr; 158(4):393-9. PubMed ID: 8317126
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunotherapy of endotoxemia and septicemia.
    Baumgartner JD; Glauser MP
    Immunobiology; 1993 Apr; 187(3-5):464-77. PubMed ID: 8330909
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Centoxin: the full story of its withdrawal.
    Andrews PA
    Br J Hosp Med; 1993 Apr 7-20; 49(7):517. PubMed ID: 8490693
    [No Abstract]   [Full Text] [Related]  

  • 31. Human monoclonal antibodies in sepsis.
    Smith C; Straube R; Wortel C
    Neth J Med; 1991 Oct; 39(3-4):177-9. PubMed ID: 1824049
    [No Abstract]   [Full Text] [Related]  

  • 32. Centoxin: the full story of its withdrawal.
    Choyce MQ
    Br J Hosp Med; 1993 Apr 7-20; 49(7):517. PubMed ID: 8490694
    [No Abstract]   [Full Text] [Related]  

  • 33. Endotoxemia and gram-negative bacteremia in swine: chemical mediators and therapeutic considerations.
    Olson NC; Dodam JR; Kruse-Elliott KT
    J Am Vet Med Assoc; 1992 Jun; 200(12):1884-93. PubMed ID: 1639693
    [No Abstract]   [Full Text] [Related]  

  • 34. Gram-negative sepsis, the sepsis syndrome, and the role of antiendotoxin monoclonal antibodies.
    Barriere SL; Guglielmo BJ
    Clin Pharm; 1992 Mar; 11(3):223-35. PubMed ID: 1611812
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Findings halt clinical trials of centoxin.
    Wagner M
    Mod Healthc; 1993 Jan; 23(4):16. PubMed ID: 10123669
    [No Abstract]   [Full Text] [Related]  

  • 36. Human monoclonal antibodies in sepsis.
    de Koning J; Westendorp RG
    Neth J Med; 1992 Apr; 40(3-4):215. PubMed ID: 1603215
    [No Abstract]   [Full Text] [Related]  

  • 37. Pilot study of anti-lipopolysaccharide human monoclonal antibody MAB-T88 in patients with gram-negative sepsis.
    Daifuku R; Panacek EA; Haenftling K; Swenson WK; Prescott AW; Johnson JL
    Hum Antibodies Hybridomas; 1993 Jan; 4(1):36-9. PubMed ID: 8431557
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Monoclonal antibodies in sepsis.
    Sheppard MJ; Kelly TW
    BMJ; 1992 Apr; 304(6833):1054-5. PubMed ID: 1586799
    [No Abstract]   [Full Text] [Related]  

  • 39. Role of monoclonal antibody therapy in the treatment of infectious disease.
    Chmel H
    Am J Hosp Pharm; 1990 Nov; 47(11 Suppl 3):S11-5. PubMed ID: 2275476
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HA-1A. A human monoclonal antibody for the treatment of gram-negative sepsis.
    Smith CR; Straube RC; Ziegler EJ
    Infect Dis Clin North Am; 1992 Mar; 6(1):253-66. PubMed ID: 1578120
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.